Regulation of memory CD8 T cell development
Regulation of memory CD8 T cell development
批准号:
8606806
负责人:
Susan M Kaech
金额:
$41.63万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2013
资助国家:
美国
项目状态:
已结题
起止时间:
2013-02-01 至 2018-01-31
关键词:
AnimalsAntigensAntiviral AgentsAreaBCL1 OncogeneBuffersCD8B1 geneCell Differentiation processCell physiologyCellsCellular ImmunityChronicCommunicable DiseasesCytokine Inducible SH2-Containing ProteinCytokine SignalingEffector CellEnvironmentExposure toFrequenciesGene ExpressionGenerationsGoalsGrantHIVHealthHepatitis CHome environmentHomeostasisHomingHumanImmuneImmune responseImmunityImmunotherapyInfectionInflammatoryInterferonsInterleukin-10Interleukin-12Interleukin-2Interleukin-7LeadLengthLifeLongevityMaintenanceMalariaMediatingMemoryModelingPathway interactionsPeripheralPlayProliferatingPropertyProtein IsoformsRegulationResearchRoleSTAT3 geneSTAT4 geneSTAT5A geneSignal PathwaySignal TransductionSourceStagingStem cellsT cell differentiationT memory cellT-Cell DevelopmentT-LymphocyteTechniquesTelomeraseTherapeuticTimeTissuesVaccinationVaccinesViralVirusWorkbasecancer therapycancer typecytokinefightinghuman FRAP1 proteinimprovedinsightkillingslong term memorylymph nodesnovelpathogenprecursor cellpreventprogramspublic health relevancereceptorresponsesecondary infectionself-renewaltranscription factor
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Memory CD8 T cells play a critical role in mediating long-term immunity against infectious disease. Developing long-lived memory CD8 T cells is currently the paramount goal of many vaccines that will fight chronic infections, such as HIV, malaria and Hepatitis C, and also against certain types of cancers. Memory CD8 T cells provide long-lived immunological protection because they proliferate, secrete antiviral cytokines and kill infected cells more rapidly than nave T cells upon antigen encounter. Memory CD8 T cells can persist for great lengths of time (up to one's lifetime) and a number of stem cell-like properties are bestowed onto these cells, such as telomerase expression and the ability to self-renew through homeostatic turnover. These functional attributes, along with the sheer increase in precursor frequency of pathogen-specific T cells, constitute the basis of long-term memory T cell-mediated immunity. Understanding how long-lived memory T cells that protect against secondary infections are formed and maintained is an important area of research because of their profound role in human health. We have identified a novel pathway controlling the formation of mature antiviral memory CD8 T cells and their precursors that involves the actions of IL-10, IL-21 and STAT3. Based on our findings, we hypothesize that memory cell fates are not necessarily "programmed" in activated CD8 T cells, but rather, require signaling from IL-10 and IL-21 to sustain mature memory CD8 T cell differentiation states and central memory (TCM) properties. In the absence of these signals, we postulate that antigen-specific CD8 T cells are prone to spontaneous effector cell differentiation and IL-10/IL-21/SOCS3 act to buffer memory CD8 T cells from steady-state or bystander inflammatory bursts to sustain memory cell potential and protective responses. In this grant we will use state of the art techniques to determine (1) when during infection IL-10/IL-21/STAT3 signaling influences memory cell fates, (2) if T cells are the physiologically relevant producers or IL-10 and IL-21 for memory CD8 T cell development, (3) whether blocking IL-2 or IL-12 signaling rescues memory CD8 T cell development in the absence of STAT3, and (4) how STAT3 and STAT4/STAT5 reciprocally control 'effector' and 'memory' CD8 T cell gene expression. This work is of high impact because it provides new mechanistic insight into cytokines and transcription factors that regulate memory CD8 T cell differentiation and homeostasis, and this could lead to improved therapeutic modulation of T cell differentiation and function during vaccination, cancer treatments and other types of immune-based therapies.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Infectious history as a determinant of age-related inflammation in Alzheimers disease
-
批准号:10663042
-
项目类别:
-
资助金额:$19.0万
-
财政年份:2023
-
负责人:Susan M Kaech
-
依托单位:
Core 1: Tumor and Microenvironment Heterogeneity Core (TMH Core)
-
批准号:10629067
-
项目类别:
-
资助金额:$44.26万
-
财政年份:2023
-
负责人:Susan M Kaech
-
依托单位:
Project 3: Chronic interferon and bile acid signaling as drivers of immunosuppression in age-related liver cancer
-
批准号:10270688
-
项目类别:
-
资助金额:$37.38万
-
财政年份:2021
-
负责人:Susan M Kaech
-
依托单位:
Project 3: Chronic interferon and bile acid signaling as drivers of immunosuppression in age-related liver cancer
-
批准号:10698108
-
项目类别:
-
资助金额:$41.16万
-
财政年份:2021
-
负责人:Susan M Kaech
-
依托单位:
Understanding how metabolic heterogeneity in cancer affects the tumor microenvironment and anti-tumor immunity
-
批准号:9981453
-
项目类别:
-
资助金额:$59.93万
-
财政年份:2020
-
负责人:Susan M Kaech
-
依托单位:
Understanding how metabolic heterogeneity in cancer affects the tumor microenvironment and anti-tumor immunity
-
批准号:10570962
-
项目类别:
-
资助金额:$58.73万
-
财政年份:2020
-
负责人:Susan M Kaech
-
依托单位:
Understanding how metabolic heterogeneity in cancer affects the tumor microenvironment and anti-tumor immunity
-
批准号:10335143
-
项目类别:
-
资助金额:$58.73万
-
财政年份:2020
-
负责人:Susan M Kaech
-
依托单位:
Understanding how metabolic heterogeneity in cancer affects the tumor microenvironment and anti-tumor immunity
-
批准号:10747827
-
项目类别:
-
资助金额:$8.11万
-
财政年份:2020
-
负责人:Susan M Kaech
-
依托单位:
Understanding and Overcoming Resistance to Cancer Immunotherapy Due to Defective Antigen Presentation
-
批准号:10337040
-
项目类别:
-
资助金额:$65.55万
-
财政年份:2019
-
负责人:Susan M Kaech
-
依托单位:
Understanding and Overcoming Resistance to Cancer Immunotherapy Due to Defective Antigen Presentation
-
批准号:10559608
-
项目类别:
-
资助金额:$64.2万
-
财政年份:2019
-
负责人:Susan M Kaech
-
依托单位:
(PQ5) Mitochondrial Heterogeneity in Melanoma Tumor and Immune Responses
-
批准号:9900670
-
项目类别:
-
资助金额:$8.05万
-
财政年份:2018
-
负责人:Susan M Kaech
-
依托单位:
(PQ5) Mitochondrial Heterogeneity in Melanoma Tumor and Immune Responses
-
批准号:10471527
-
项目类别:
-
资助金额:$7.95万
-
财政年份:2018
-
负责人:Susan M Kaech
-
依托单位:
(PQ5) Mitochondrial Heterogeneity in Melanoma Tumor and Immune Responses
-
批准号:10248406
-
项目类别:
-
资助金额:$65.1万
-
财政年份:2018
-
负责人:Susan M Kaech
-
依托单位:
(PQ5) Mitochondrial Heterogeneity in Melanoma Tumor and Immune Responses
-
批准号:10471297
-
项目类别:
-
资助金额:$63.8万
-
财政年份:2018
-
负责人:Susan M Kaech
-
依托单位:
Targeting the Immune System in Mouse Models of Lung Adenocarcinoma
-
批准号:8902602
-
项目类别:
-
资助金额:$61.03万
-
财政年份:2015
-
负责人:Susan M Kaech
-
依托单位:
Targeting the Immune System in Mouse Models of Lung Adenocarcinoma
-
批准号:9055670
-
项目类别:
-
资助金额:$59.19万
-
财政年份:2015
-
负责人:Susan M Kaech
-
依托单位:
Regulation of memory CD8 T cell development
-
批准号:8532603
-
项目类别:
-
资助金额:$39.08万
-
财政年份:2013
-
负责人:Susan M Kaech
-
依托单位:
Regulation of memory CD8 T cell development
-
批准号:8997417
-
项目类别:
-
资助金额:$41.63万
-
财政年份:2013
-
负责人:Susan M Kaech
-
依托单位:
The role of STAT3 in effector and memory CD8 T cell longevity and metabolism
-
批准号:8226852
-
项目类别:
-
资助金额:$24.87万
-
财政年份:2012
-
负责人:Susan M Kaech
-
依托单位:
The role of STAT3 in effector and memory CD8 T cell longevity and metabolism
-
批准号:8415501
-
项目类别:
-
资助金额:$19.54万
-
财政年份:2012
-
负责人:Susan M Kaech
-
依托单位:
国内基金
海外基金
Neo-antigens暴露对肾移植术后体液性排斥反应的影响及其机制研究
-
批准号:2022J011295
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:王亚伟
-
依托单位:
结核分枝杆菌持续感染期抗原(latency antigens)的重组BCG疫苗研究
-
批准号:30801055
-
项目类别:青年科学基金项目
-
资助金额:19.0万元
-
批准年份:2008
-
负责人:王丽梅
-
依托单位: